NCT05120518Recruiting
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Source: ClinicalTrials.gov · Last updated 3 Jun 2026
Brief summary (registry, in English)
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 3 Nov 2021
- Start date
- 14 Aug 2019
- Primary completion date
- 14 Aug 2029
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Diseases
- Childhood cancers
- NCT number
- NCT05120518
What you commit to
- Study type: Observational
- Planned participants: 150
- From 14 Aug 2019 to the primary completion date, 14 Aug 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Signed consent for post mortem tissue donation and autopsy not obtained
Who the study is looking for
- Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology)
- Signed consent for post mortem tissue donation and autopsy
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ann & Robert H. Lurie Children's Hospital of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.